Group One Trading
BNTC icon

Group One Trading’s Benitec Biopharma BNTC Stock Holding History

Group One Trading’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$5.85K – 8430
2025
Q2 		$5.85K Buy
+500
New +$7K ﹤0.01% 7014

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Group One Trading's BNTC Position: Q1 2026 in Review

Group One Trading held its Benitec Biopharma (BNTC) position steady in Q1 2026 at 89 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #7220.

Group One Trading first reported a position in BNTC in Q3 2021 and has held it in 19 quarters since. The position peaked at $7K in Q3 2021. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Group One Trading held 89 shares of Benitec Biopharma worth $948 as of Q1 2026.
  • Group One Trading left its Benitec Biopharma share count unchanged in Q1 2026.
  • Benitec Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7220 holding.
  • Group One Trading first reported a position in Benitec Biopharma in Q3 2021 and has held it in 19 quarters since.
  • Group One Trading's Benitec Biopharma position peaked at $7K in Q3 2021.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.